Outcomes after endovascular treatment for anterior circulation stroke presenting as wake-up strokes are not different than those with witnessed onset beyond 8 hours

Journal of NeuroInterventional Surgery

Volumn 7, Issue 12, 2015, Pages 875-880

  Aghaebrahim, Amin ^a   Leiva Salinas, Carlos ^b   Jadhav, Ashutosh P ^a   Jankowitz, Brian ^a   Zaidi, Syed ^a   Jumaa, Mouhammad ^a   Urra, Xabi ^a,c   Amorim, Edilberto ^a   Zhu, Guangming ^b   Giurgiutiu, Dan Victor ^a   Horev, Anat ^a   Reddy, Vivek ^a   Hammer, Maxim ^a   Wechsler, Lawrence ^a   Wintermark, Max ^b   Jovin, Tudor ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANTERIOR CIRCULATION LARGE VESSEL OCCLUSION STROKE; ARTICLE; BRAIN HEMATOMA; BRAIN INFARCTION; BRAIN INFARCTION SIZE; CEREBROVASCULAR ACCIDENT; COMPUTER ASSISTED TOMOGRAPHY; ENDOVASCULAR SURGERY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MECHANICAL THROMBECTOMY; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCLUSIVE CEREBROVASCULAR DISEASE; PENUMBRA DISEASE; PRIORITY JOURNAL; RANKIN SCALE; RECANALIZATION; RETROSPECTIVE STUDY; TREATMENT RESPONSE; WAKE UP STROKE; AGED; BRAIN ISCHEMIA; FIBRINOLYTIC THERAPY; MIDDLE AGED; PROCEDURES; PROSPECTIVE STUDY; RADIOGRAPHY; STROKE; TIME FACTOR; TREATMENT OUTCOME; TRENDS; VERY ELDERLY;

FIBRINOLYTIC AGENT; TISSUE PLASMINOGEN ACTIVATOR;

AGED; AGED, 80 AND OVER; BRAIN ISCHEMIA; ENDOVASCULAR PROCEDURES; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; STROKE; THROMBOLYTIC THERAPY; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME;

EID: 84947265727     PISSN: 17598478     EISSN: 17598486     Source Type: Journal    
DOI: 10.1136/neurintsurg-2014-011316     Document Type: Article

References (21)

1. Natarajan S, Snyder K, Siddiqui A, et al. Safety and effectiveness of endovascualr therapy after 8 hours of acute ischemic stroke onset and wake-up strokes. Stroke 2009;40:3269-74.
2. Jovin T, Liebeskind D, Gupta R, et al. Imaging-based endovascular therapy for acute stroke due to proximal intracranial anterior circulation occlusion treated beyond 8 hours from time last seen well. Stroke 2011;42:2206-11.
3. Fink JN, Kumar S, Horkan C, et al. The stroke patient who woke up: clinical and radiological features, including diffusion and perfusion MRI. Stroke 2002;33:988-93.
4. Mackey J, Kleindorfer D, Sucharew H, et al. Population-based study of wake-up strokes. Neurology 2011;76:1662-7.
5. Williams DO, Borer J, Braunwald E, et al. Intravenous recombinant tissue-type plasminogen activator in patients with acute myocardial infarction: a report from the NHLBI thrombolysis in myocardial infarction trial. Circulation 1986;73:338-46.
6. Furlan A, Higashida R, Wechsler L, et al. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral thromboembolism. JAMA 1999;282:2003-11.
7. Manawadu D, Bodla S, Jarosz J, et al. Thrombolysis in selected patients with wake up stroke is feasible with similar safety as thrombolysis in 0-4.5 hours. Presented at the International Stroke Conference 2012; 1 February 2012, New Orleans, LA.
8. Fisher M, Albers GW. Advanced imaging to extend the therapeutic time window of acute ischemic stroke. Ann Neurol 2013;73:4-9.
9. Jovin T, Demchuk A, Gupta R. Pathophysiology of acute ischemic stroke. CONTINUUM 2008;14:28-45.
10. Zaidi SF, Aghaebrahim A, Urra X, et al. Final infarct volume is a stronger predictor of outcome than recanalization in patients with proximal middle cerebral artery occlusion treated with endovascular therapy. Stroke 2012;43:3238-44.
11. Yoo AJ, Chaudhry ZA, Nogueira RG, et al. Infarct volume is a pivotal biomarker after intra-arterial stroke therapy. Stroke 2012;43:1323-30.
12. Jovin TG, Yonas H, Gebel JM, et al. The cortical ischemic core and not the consistently present penumbra is a determinant of clinical outcome in acute middle cerebral artery occlusion. Stroke 2003;34:2426-33.
13. Davalos A, Blanco M, Pedraza S, et al. The clinical-DWI mismatch a new diagnostic approach to the brain tissue at risk of infarction. Neurology 2004;62:2187-92.
14. Copen WA, Rezai Gharai L, Barak ER, et al. Existance of the diffusion-perfusion mismatch within 24hrs after onset of acute stroke: dependence of proximal arterial occlusion. Radiology 2009;250:878-86.
15. Mazighi M, Chaudhry SA, Ribo M, et al. Impact of onset-to-reperfusion time on stroke mortality: a collaborative pooled analysis. Circulation 2013;127:1980-5.
16. Lansberg MG, Straka M, Kemp S, et al. MRI profile and response to endovascular reperfusion after stroke (DEFUSE 2): a prospective cohort study. Lancet Neurol 2012;11:860-7.
17. Dani KA, Thomas RGR, Chappell FM, et al. Computed tomography and magnetic resonance perfusion imaging in ischemic stroke: definitions and thresholds. Ann Neurol 2011;70:384-401.
18. Smith WS, Sung G, Saver J, et al. Mechanical thrombectomy for acute ischemic stroke: final results of the Multi MERCI trial. Stroke 2008;39:1205-12.
19. Bose A, Henkes H, Alfke K, et al. The Penumbra system: a mechanical device for the treatment of acute stroke due to thromboembolism. AJNR Am J Neuroradiol 2008;29:1409-13.
20. No author listed]. Tissue plasminogen activator for acute ischemic stroke: National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med 1995;333:1581-7.
21. Millan M, Aleu A, Almendrote M, et al. Safety and effectiveness of endovascular treatment of stroke with unknown time of onset. Cerebrovasc Dis 2014;37:134-40.